scholarly article | Q13442814 |
P819 | ADS bibcode | 2000PNAS...97..430W |
P356 | DOI | 10.1073/PNAS.97.1.430 |
P932 | PMC publication ID | 26680 |
P698 | PubMed publication ID | 10618435 |
P5875 | ResearchGate publication ID | 51363957 |
P50 | author | Elliott D. Kieff | Q43399614 |
P2093 | author name string | L Wang | |
S R Grossman | |||
P2860 | cites work | HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter | Q22007982 |
CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex | Q22008610 | ||
The TAF(II)250 subunit of TFIID has histone acetyltransferase activity | Q24310327 | ||
Synergistic activation of transcription by CBP and p53 | Q24311979 | ||
The Epstein-Barr Virus Nuclear Protein 2 Acidic Domain Forms a Complex with a Novel Cellular Coactivator That Can Interact with TFIIE | Q24329182 | ||
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A | Q24336667 | ||
Factors associated with the mammalian RNA polymerase II holoenzyme | Q24546284 | ||
The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2 | Q24564767 | ||
CREB-binding protein/p300 are transcriptional coactivators of p65 | Q24569596 | ||
A histone deacetylase corepressor complex regulates the Notch signal transduction pathway | Q24598533 | ||
Transcription factor-specific requirements for coactivators and their acetyltransferase functions | Q28260156 | ||
Differential roles of p300 and PCAF acetyltransferases in muscle differentiation | Q28276083 | ||
Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat | Q28282041 | ||
Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor | Q28286827 | ||
p300/MDM2 complexes participate in MDM2-mediated p53 degradation | Q28288274 | ||
Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300 | Q28301874 | ||
p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen | Q28565821 | ||
Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome | Q29618064 | ||
Alteration of nucleosome structure as a mechanism of transcriptional regulation | Q29620047 | ||
The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. | Q33292571 | ||
p53-dependent cell cycle control: response to genotoxic stress | Q33547812 | ||
E2F target genes and cell-cycle checkpoint control | Q33638698 | ||
Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structure | Q33643991 | ||
Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation. | Q33786088 | ||
E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor | Q33856709 | ||
Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300 | Q33996796 | ||
An activity gel assay detects a single, catalytically active histone acetyltransferase subunit in Tetrahymena macronuclei | Q34120369 | ||
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation | Q34324039 | ||
E2F1 and E1A(12S) have a homologous activation domain regulated by RB and CBP. | Q34381615 | ||
Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. | Q34625121 | ||
Histone acetyltransferase activity of yeast Gcn5p is required for the activation of target genes in vivo | Q35192911 | ||
Critical residues for histone acetylation by Gcn5, functioning in Ada and SAGA complexes, are also required for transcriptional function in vivo | Q35193069 | ||
The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein | Q35648541 | ||
Retracted: Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors | Q35656534 | ||
Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. | Q35829475 | ||
The N-terminal half of EBNA2, except for seven prolines, is not essential for primary B-lymphocyte growth transformation. | Q35859057 | ||
Association of p300 and CBP with simian virus 40 large T antigen | Q36560644 | ||
The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains. | Q36635773 | ||
Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation | Q36689004 | ||
An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator | Q36820857 | ||
A region of herpes simplex virus VP16 can substitute for a transforming domain of Epstein-Barr virus nuclear protein 2 | Q37175014 | ||
The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. | Q39551287 | ||
The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. | Q39595067 | ||
Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation | Q41044061 | ||
Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator | Q41133317 | ||
Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa | Q45781476 | ||
Early events in Epstein-Barr virus infection of human B lymphocytes | Q45855126 | ||
Binding of general transcription factor TFIIB to an acidic activating region | Q59058683 | ||
Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID | Q59070657 | ||
Critical structural elements of the VP16 transcriptional activation domain | Q67912152 | ||
Purification and characterization of two porcine liver nuclear histone acetyltransferases | Q68708782 | ||
Binding of NF-KB-like factors to regulatory sequences of the c-myc gene | Q70237251 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | virus | Q808 |
Epstein–Barr virus | Q6900 | ||
P304 | page(s) | 430-435 | |
P577 | publication date | 2000-01-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter | |
P478 | volume | 97 |